Indo US Bio-Tech Ltd.(IN:INDOUS)
₹63.51-1.75 (-2.68%)
IN:INDOUS
Indo US Bio-Tech Ltd. financials statements
₹63.51
At close:-1.75 (-2.68%)
Want to see IN:INDOUS full AI Analyst Report?
Indo US Bio-Tech Ltd. (INDOUS) Ratios
0 Followers
Indo US Bio-Tech Ltd. Ratios
IN:INDOUS's free cash flow for Q2 2025 was ₹-13.17M. For the 2025 fiscal year, IN:INDOUS's free cash flow was decreased by ₹-6.07M and operating cash flow was ₹-7.10M. See a summary of the company’s cash flow.
| Ratios | Mar 25 | Mar 24 |
|---|---|---|
| Liquidity Ratios | ||
| Current Ratio | 3.05 | 5.31 |
| Quick Ratio | 0.52 | 0.98 |
| Cash Ratio | 0.15 | 0.02 |
| Solvency Ratio | 0.35 | 0.84 |
| Operating Cash Flow Ratio | -0.32 | 0.00 |
| Short-Term Operating Cash Flow Coverage | -0.35 | 0.00 |
| Net Current Asset Value | ₹ 801.29M | ₹ 674.02M |
| Leverage Ratios | ||
| Debt-to-Assets Ratio | 0.28 | 0.15 |
| Debt-to-Equity Ratio | 0.40 | 0.19 |
| Debt-to-Capital Ratio | 0.29 | 0.16 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.04 |
| Financial Leverage Ratio | 1.44 | 1.25 |
| Debt Service Coverage Ratio | 0.42 | 0.02 |
| Interest Coverage Ratio | 7.18 | 0.15 |
| Debt to Market Cap | 0.19 | 0.05 |
| Interest Debt Per Share | 19.58 | 8.12 |
| Net Debt to EBITDA | 1.81 | 65.28 |
| Profitability Margins | ||
| Gross Profit Margin | 27.32% | 28.38% |
| EBIT Margin | 14.64% | 0.20% |
| EBITDA Margin | 15.45% | 0.22% |
| Operating Profit Margin | 14.59% | 0.20% |
| Pretax Profit Margin | 12.60% | 15.92% |
| Net Profit Margin | 11.88% | 15.67% |
| Continuous Operations Profit Margin | 11.88% | 0.18% |
| Net Income Per EBT | 94.27% | 98.41% |
| EBT Per EBIT | 86.41% | 7851.62% |
| Return on Assets (ROA) | 9.86% | 16.63% |
| Return on Equity (ROE) | 14.18% | 20.72% |
| Return on Capital Employed (ROCE) | 17.22% | 0.26% |
| Return on Invested Capital (ROIC) | 11.71% | 0.23% |
| Return on Tangible Assets | 9.86% | 16.63% |
| Earnings Yield | 6.68% | 5.20% |
| Efficiency Ratios | ||
| Receivables Turnover | 8.03 | 6.59 |
| Payables Turnover | 179.13 | 64.01 |
| Inventory Turnover | 0.80 | 1.05 |
| Fixed Asset Turnover | 9.42 | 10.15 |
| Asset Turnover | 0.83 | 1.06 |
| Working Capital Turnover Ratio | 1.46 | 0.00 |
| Cash Conversion Cycle | 497.94 | 396.61 |
| Days of Sales Outstanding | 45.47 | 55.38 |
| Days of Inventory Outstanding | 454.50 | 346.93 |
| Days of Payables Outstanding | 2.04 | 5.70 |
| Operating Cycle | 499.98 | 402.31 |
| Cash Flow Ratios | ||
| Operating Cash Flow Per Share | -6.27 | 0.00 |
| Free Cash Flow Per Share | -7.47 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | -5.22 | 0.00 |
| Capital Expenditure Coverage Ratio | -5.22 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.34 | 0.00 |
| Operating Cash Flow to Sales Ratio | -0.11 | 0.00 |
| Free Cash Flow Yield | -7.63% | -0.00% |
| Valuation Ratios | ||
| Price-to-Earnings (P/E) Ratio | 14.97 | 1644.51 |
| Price-to-Sales (P/S) Ratio | 1.78 | 3.01 |
| Price-to-Book (P/B) Ratio | 2.12 | 3.98 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -13.11 | -31045.92 |
| Price-to-Operating Cash Flow Ratio | -15.61 | 34266215.06 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.00 |
| Enterprise Value Multiple | 13.32 | 1464.05 |
| Enterprise Value | 2.27B | 3.27B |
| EV to EBITDA | 13.32 | 1464.05 |
| EV to Sales | 2.06 | 3.15 |
| EV to Free Cash Flow | -15.17 | -32494.74 |
| EV to Operating Cash Flow | -18.07 | 35865320.73 |
| Tangible Book Value Per Share | 46.12 | 39.16 |
| Shareholders’ Equity Per Share | 46.12 | 39.16 |
| Tax and Other Ratios | ||
| Effective Tax Rate | 0.06 | 0.00 |
| Revenue Per Share | 55.04 | 51.78 |
| Net Income Per Share | 6.54 | 8.11 |
| Tax Burden | 0.94 | 0.98 |
| Interest Burden | 0.86 | 78.47 |
| Research & Development to Revenue | 0.00 | 0.06 |
| SG&A to Revenue | 0.00 | 0.03 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 |
| Income Quality | -0.90 | 0.00 |
Currency in INR

